HAIXI PHARMA Allocates Idle Capital to Financial Products

Stock News

Feb 05

HAIXI PHARMA (02637) has announced that on October 24, 2025, Fujian Haixi New Drug Creation Co., Ltd., acting as an investor, utilized its idle funds to subscribe to (i) HKD 200 million worth of fund-linked notes (the Fund-Linked Notes) from the 2025-32 series, issued under the USD 1 billion guaranteed structured notes program by Essence Global Investment Limited; and (ii) up to HKD 200 million in China Rock Fund SPC. The subscription to China Rock Fund, together with the subscription to the Fund-Linked Notes, is referred to as the Subscriptions. The rational and effective use of temporarily idle funds is expected to enhance the company's capital returns. This move aligns with the company's core objective of ensuring fund security and liquidity while meeting the capital requirements for the group's daily operations and dividend distributions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1136379883"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1136379883\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1136379883?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-05 16:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1136379883","market":"us","top_or_hot":-1,"title":"HAIXI PHARMA Allocates Idle Capital to Financial Products","media":"Stock News","content":"<p>HAIXI PHARMA (02637) has announced that on October 24, 2025, Fujian Haixi New Drug Creation Co., Ltd., acting as an investor, utilized its idle funds to subscribe to (i) HKD 200 million worth of fund-linked notes (the Fund-Linked Notes) from the 2025-32 series, issued under the USD 1 billion guaranteed structured notes program by Essence Global Investment Limited; and (ii) up to HKD 200 million in China Rock Fund SPC. The subscription to China Rock Fund, together with the subscription to the Fund-Linked Notes, is referred to as the Subscriptions. The rational and effective use of temporarily idle funds is expected to enhance the company's capital returns. This move aligns with the company's core objective of ensuring fund security and liquidity while meeting the capital requirements for the group's daily operations and dividend distributions.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HAIXI PHARMA Allocates Idle Capital to Financial Products</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHAIXI PHARMA Allocates Idle Capital to Financial Products\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-02-05 16:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HAIXI PHARMA (02637) has announced that on October 24, 2025, Fujian Haixi New Drug Creation Co., Ltd., acting as an investor, utilized its idle funds to subscribe to (i) HKD 200 million worth of fund-linked notes (the Fund-Linked Notes) from the 2025-32 series, issued under the USD 1 billion guaranteed structured notes program by Essence Global Investment Limited; and (ii) up to HKD 200 million in China Rock Fund SPC. The subscription to China Rock Fund, together with the subscription to the Fund-Linked Notes, is referred to as the Subscriptions. The rational and effective use of temporarily idle funds is expected to enhance the company's capital returns. This move aligns with the company's core objective of ensuring fund security and liquidity while meeting the capital requirements for the group's daily operations and dividend distributions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"","article_id":"1136379883","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1136379883","pubTimestamp":1770280827,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"HAIXI PHARMA (02637) has announced that on October 24, 2025, Fujian Haixi New Drug Creation Co., Ltd., acting as an investor, utilized its idle funds to subscribe to (i) HKD 200 million worth of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159940":"金融","BK1191":"制药","02637":"海西新药"},"translate_title":"海西药业闲置资金配置理财产品","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159940":1,"02637":1},"content_text":"HAIXI PHARMA (02637) has announced that on October 24, 2025, Fujian Haixi New Drug Creation Co., Ltd., acting as an investor, utilized its idle funds to subscribe to (i) HKD 200 million worth of fund-linked notes (the Fund-Linked Notes) from the 2025-32 series, issued under the USD 1 billion guaranteed structured notes program by Essence Global Investment Limited; and (ii) up to HKD 200 million in China Rock Fund SPC. The subscription to China Rock Fund, together with the subscription to the Fund-Linked Notes, is referred to as the Subscriptions. The rational and effective use of temporarily idle funds is expected to enhance the company's capital returns. This move aligns with the company's core objective of ensuring fund security and liquidity while meeting the capital requirements for the group's daily operations and dividend distributions.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}